Sovran Advisors, LLC Sarepta Therapeutics, Inc. Transaction History
Sovran Advisors, LLC
- $770 Billion
- Q1 2025
A detailed history of Sovran Advisors, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Sovran Advisors, LLC holds 57,509 shares of SRPT stock, worth $3.55 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
57,509
Previous 27,015
112.88%
Holding current value
$3.55 Million
Previous $3.21 Billion
3.64%
% of portfolio
0.4%
Previous 0.46%
Shares
2 transactions
Others Institutions Holding SRPT
# of Institutions
524Shares Held
86MCall Options Held
1.55MPut Options Held
1.37M-
Black Rock Inc. New York, NY10.3MShares$638 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$561 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$537 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$267 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$251 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $5.41B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...